Verition Fund Management
NURO

Verition Fund Management’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Verition Fund Management’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,351
Closed -$110K – 2876
2021
Q3 		$110K Buy
+1,351
New +$121K ﹤0.01% 1697

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Verition Fund Management's NURO Position: Q4 2021 in Review

Verition Fund Management sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2021, closing a stake of 1,351 shares — an estimated $110K sold.

Verition Fund Management first reported a position in NURO in Q3 2021 and held it in 1 quarter. The position peaked at $110K in Q3 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q4 2021.

  • Verition Fund Management reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Verition Fund Management sold 1,351 NeuroMetrix, Inc. Common Stock shares in Q4 2021, an estimated $110K.
  • Verition Fund Management first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Verition Fund Management's NeuroMetrix, Inc. Common Stock position peaked at $110K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2021.

Based on Verition Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.